Ignite Creation Date:
2024-05-06 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05246033
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2022-02-09
Brief Title:
A Dose Escalation Trial Evaluating Safety Efficacy and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
Sponsor:
Ascendis Pharma AS
Organization:
Ascendis Pharma AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-09
First Submit QC Date:
February 9 2022
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL